2025 annual financial data
Enanta Pharmaceuticals 2025 Operating margin
Enanta Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -130.65%.
Operating income was -85,349,000 USD and net income was -81,889,000 USD.
Operating cash flow was -19,272,000 USD.
Get free Enanta Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 65,324,000 USD
- Operating income
- -85,349,000 USD
- Net income
- -81,889,000 USD
- Operating cash flow
- -19,272,000 USD